Interchangeability of meningococcal group C conjugate vaccines with different carrier proteins in the United Kingdom infant immunisation schedule-Reference-Cited by-同舟云学术

Interchangeability of meningococcal group C conjugate vaccines with different carrier proteins in the United Kingdom infant immunisation schedule

Published:2015-01 Issue:5 Volume:33 Page:648-655
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Ladhani Shamez N.^ORCID,Andrews Nick J.,Waight Pauline,Hallis Bassam,Matheson Mary,England Anna,Findlow Helen,Bai Xilian,Borrow Ray,Burbidge Polly,Pearce Emma,Goldblatt David,Miller Elizabeth

Funder

Research and Development Directorate of the United Kingdom Department of Health

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference33 articles.

1. Chapter 12: Meningococcal;Public Health England,2013

2. Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United Kingdom;Southern;Clin Vaccine Immunol,2009

3. Combination vaccines containing DTPa-Hib: impact of IPV and coadministration of CRM197 conjugates;Dagan;Expert Rev Vaccines,2008

4. Glycoconjugate vaccines and immune interference: a review;Dagan;Vaccine,2010

5. Glycoconjugate vaccines and immune interactions, and implications for vaccination schedules;Borrow;Expert Rev Vaccines,2011

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune responses to typhoid conjugate vaccine in a two dose schedule among Nepalese children <2 years of age;Vaccine;2024-03

2. A phase IV, multi-centre, randomized clinical trial comparing two pertussis-containing vaccines in pregnant women in England and vaccine responses in their infants;BMC Medicine;2021-06-08

3. A phase IV, multi-centre, randomized clinical trial comparing two pertussis-containing vaccines in pregnant women in England and vaccine responses in their infants;2021-01-25

4. Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT)vs. a licensed quadrivalent meningococcal tetanus toxoid-conjugate vaccine in meningococcal vaccine-naïve and meningococcal C conjugate vaccine-primed toddlers: a phase III randomised study;Epidemiology and Infection;2021

5. Randomized clinical trial of DTaP5-HB-IPV-Hib vaccine administered concomitantly with meningococcal serogroup C conjugate vaccines during the primary infant series;Vaccine;2020-07